Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention

2016 May   American Journal of Therapeutics   Singh S, Arora RR, Singh M, Khosla S

The use of Eicosapentaenoic acid as an adjunct therapy for high-risk patient has shown to help decrease cardiovascular risk. The reduction in risk is performed not only by decreasing triglyceride but also by reducing vascular inflammation.